The newest generation of antiobesity medications (AOMs)—GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), dual action GLP-1/GIP combinations, triple action injectables, and emerging injectable and oral medications—have changed the landscape for weight management, bringing weight loss success to many for whom weight maintenance had previously not been possible.
Trending
- Nutrition Therapy for Chronic Critical Illness
- Great Debates: Metabolic Health and Weight
- Flexible Meal Planning for Autism and ADHD
- Beyond the Prison Bars
- CPE Monthly: Trends in Oncology Nutrition: Eating on a Schedule
- Editor’s Spot: Ringing in 2026
- Clinical Nutrition: The Real-Food Formula Dilemma
- Food for Thought: Atrial Fibrillation and Nutrition